Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Wyeth heartburn drug is challenged

Wall Street Journal (subscription required), December 26, 2007
Wyeth faces an uphill struggle to protect patent exclusivity for its blockbuster drug Protonix after Teva Pharmaceutical Industries Ltd. launched a generic version of the heartburn pill in the U.S. market. Wyeth said it would file a patent-infringement claim against the Israeli generic-drug maker, seeking lost profits and other damages as a result of Teva's new product.